← Back to VTS Methodology
VTS Scoring Log

Core Peptides

US-facing gray market· Lyophilized vials· Scored July 2026· corepeptides.com →

Core Peptides is the longest-running vendor in the current catalog - 7+ years in operation with over 100 SKUs - and scores lowest on documentation among established operations. The site claims independent verification but names no lab, publishes no COA database, and provides no lot codes. The gap between operational scale and verifiable documentation is what drives the Low score: it is not that testing is absent, but that none of the claimed testing is independently confirmable from public materials.

28 /100
Low Transparency
A long-running operation with a large catalog and third-party testing claims, but verification is structurally blocked: no public COA database, no named lab, no batch-level traceability accessible to buyers before or after purchase. Documentation discipline lags considerably behind the "independently verified" marketing claim.
Dimension Scores
DimensionMaxNotesScore
Third-Party Testing Practice30Homepage states "US lab-tested peptides are independently verified for purity." About page repeats the independent verification claim. No dedicated lab testing page, no testing protocol detail, no named lab, no method description (HPLC, MS, etc.), and no indication of per-batch vs. periodic testing. The claim exists; the evidence chain does not.10/30
Batch Traceability & Verification20No lot codes visible on product pages, no batch number system described, no COA searchable by batch. No mechanism exists for a buyer to match what they received to a specific test result. Generic documentation is the implied model.3/20
COA Accessibility15No COA database, no COA links on product pages, no specimen COA publicly available anywhere on the site. No stated process for requesting COAs. Accessibility is effectively absent from the public-facing site.2/15
COA Completeness15Cannot score: no COA is publicly accessible to evaluate. The testing claim exists but no documentation is available for review. Scored as insufficient evidence rather than zero, acknowledging the claim without being able to verify the substance behind it.3/15
Testing Recency10No dated COAs publicly available. Cannot assess whether testing is current. Minor credit for active site maintenance (OG image updated July 2026) suggesting the operation is active.2/10
Policy Transparency5Shipping and returns page exists at a dedicated URL. 30-day refund window stated. No lot-mismatch or quality-incident specific language, no RMA process described. Basic policy present but thin on specifics relative to what a buyer needs to know.3/5
Operational Track Record5Site states "serving the research community for over 7 years." WordPress OG modified date of July 2026 and active product catalog confirm ongoing operation. Domain registered and maintained over multiple years. Strongest dimension relative to the score.5/5
Total28/100
Community Signal
Independent Test Results
No community-commissioned independent test results identified in public forums as of July 2026. Community testing coverage for Core Peptides is limited relative to their catalog size and operational history.
Community Experience
Core Peptides appears in vendor discussion threads as a budget-accessible option with a broad catalog. Community references are largely neutral on quality specifics; the operation's longevity is the primary positive signal cited.
Scoring Notes
The gap between claim and evidence
Core Peptides' primary transparency problem is not that they test poorly - it's that they provide no public mechanism to verify that they test at all. "Independently verified" is a claim. A named lab, a batch-specific COA, or a public test results page is evidence. The gap between those two things is the score.
What would change the score
Adding a dedicated lab testing page naming the lab and method, publishing batch-specific COAs searchable by lot number, and expanding the refund policy to include lot-quality incidents would move this score substantially. The operational track record and catalog size are genuine strengths the testing infrastructure currently undermines.